PHASE II TRIAL OF AKT INHIBITOR MK-2206 IN PATIENTS WITH ADVANCED BREAST CANCER WHO HAVE TUMORS WITH PIK3CA OR AKT MUTATIONS, AND/OR PTEN LOSS/PTEN MUTATION

Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation

Abstract Background The PI3K/AKT pathway is activated through PIK3CA or AKT1 mutations and PTEN loss in breast cancer.We conducted a phase II trial with an allosteric AKT inhibitor MK-2206 in patients with advanced breast Wire Shelving cancer who had tumors with PIK3CA/AKT1 mutations and/or PTEN loss/mutation.Methods The primary endpoint was object

read more


Influence of the structural changes on cavitation resistance of Al18SiCuMg alloy produced by rheocasting process

02 Sensor The influence of stirring speeds of 1000 and 1500 r/min on the microstructure of Al18SiCuMg alloy was investigated.The smaller size of Si particles of rheocast sample obtained by higher cooling rate and higher stirring speed was achieved.According to the results of cavitation test, the cavitation rate of the rheocast sample produced by 15

read more